It offers dual benefits of blood glucose control and weight management
Characterization of the GSTU10-10 isoenzyme revealed that it has an antioxidant catalytic function by acting as a hydroperoxidase and has a very low K m for GSH suggesting that GSTU10-10 is able to perform efficient catalysis under conditions where GSH concentrations are low, e.g., during oxidative stress (Skopelitou et al., 2015)
In patients with coexisting obesity and risky drinking patterns, GLP1 therapy has been associated with modest decreases in alcohol intake alongside weight loss
The operative note must support the acute timing
Cagrilintide showed similar directional improvements, though the magnitude was generally proportional to the degree of weight loss rather than suggesting independent cardiovascular effects
[22] Regular monitoring of weight, tolerability, and metabolic parameters is essential throughout treatment